Skip to main content
Mallory
HighVulnerability

CVE-2026-12645: Authenticated remote code execution in Ivanti Neurons for ITSM

Published Sep 8, 2026 · Updated 1 month ago
Trending this weekNot trendingOutside this week’s top 100
Mention activity · 30 daysNo mention activity in the last 30 days.
CVSS8.8High · v3.1
EPSS1.5%75th percentile
CISA KEVNoNot listed
In the wildNoneNo exploitation reported
Vendor
Ivanti
IdentifiersCVE-2026-12645CWE-862 · Missing Authorization

CVE-2026-12645 is a missing-authorization vulnerability in Ivanti Neurons for ITSM that allows a remote authenticated attacker to execute arbitrary code on the server. The affected range is initially identified as versions before 2026.2, although NVD's affected-product configuration also includes 2026.2. The specific vulnerable function and exploitation mechanism are not identified.

Do you run this?See affected versions in your environment and whether adversaries are exploiting this vulnerability against assets like yours.
Check your exposure
Analyst brief

Impact, mitigation & remediation

What it means and what to do now: patch path, interim mitigations, and the assume-compromise checklist.

Impact

What an attacker gets, and what they’ve been doing with it.

Successful exploitation permits arbitrary server-side code execution, potentially compromising the Neurons for ITSM application and its accessible data or services. The execution privilege level and effects on systems beyond the affected server are not established.

Mitigation

If you can’t patch tonight, do this now.

Until patched, restrict Neurons for ITSM service and administration interfaces to trusted users and networks, reduce internet exposure through network segmentation, and enforce strong authentication and least privilege. Restrict and review privileged and default accounts, use non-administrative service execution where supported, and monitor application and server logs for unauthorized activity or suspicious code execution. These controls reduce exposure but do not correct the authorization flaw.

Remediation

Patch, then assume compromise.

Apply Ivanti's September 2026 security patches to affected on-premises Neurons for ITSM deployments running versions 2025.2 through 2026.1, or upgrade to a vendor-confirmed fixed release. Advisories identify version 2026.2 or later as resolved, but NVD also lists 2026.2 as affected; verify the installed build and applicable patch status against Ivanti's deployment-specific guidance. Ivanti patched all cloud and SaaS landscapes on August 9, 2026, without requiring customer action.

Public exploits

Exploits

No public exploits tracked yet. Mallory keeps watching.

View more in app →
No public exploit code observed for this vulnerability. Mallory keeps watching.
Exposure surface

Affected products & vendors

Products and vendors Mallory has correlated with this vulnerability. Open in Mallory to drill down to specific CPE configurations and version ranges.

VendorProductType
IvantiNeurons For Itsmapplication
FAQ

Frequently asked questions

Is CVE-2026-12645 exploited in the wild?
As of Oct 11, 2026, Mallory has no reports of CVE-2026-12645 being exploited in the wild. It is not listed in CISA KEV.
Is there a public exploit for CVE-2026-12645?
As of Oct 11, 2026, Mallory has found no public exploit for CVE-2026-12645.
Is there a patch for CVE-2026-12645?
Apply Ivanti's September 2026 security patches to affected on-premises Neurons for ITSM deployments running versions 2025.2 through 2026.1, or upgrade to a vendor-confirmed fixed release. Advisories identify version 2026.2 or later as resolved, but NVD also lists 2026.2 as affected; verify the installed build and applicable patch status against Ivanti's deployment-specific guidance.
What products are affected by CVE-2026-12645?
Ivanti Neurons For Itsm.
How severe is CVE-2026-12645?
CVE-2026-12645 has a CVSS v3.1 score of 8.8 (High) and an EPSS score of 1.5% (75th percentile) as of Oct 11, 2026.
Mallory platform

The version that knows your environment.

This page is what’s public. Mallory adds the parts that aren’t: which of your assets are affected, which adversaries are exploiting it right now, and which detections to deploy tonight.
Exposure mappingQuery your assets running an affected version, and investigate the blast radius.
Threat actor evidenceEvery report linking this CVE to a named adversary.
Associated malwareMalware families linked to this CVE, with evidence and IOCs.
Detection signaturesYARA, Sigma, Snort, and vendor rules, auto-deployed to your SIEM.
Vendor-by-vendor mappingCross-references every affected SKU, including bundled OEM variants.
Social activity6Community discussion across Reddit, Mastodon, and other social sources.